Table 1 Basic clinicopathologic characteristics in stage T1a solitary papillary thyroid carcinoma.
Characteristics | Case n = 493(%) | Cervical CLNM (%) | x2 | p value | |
|---|---|---|---|---|---|
No | Yes | ||||
Gender | Â | Â | Â | 5.432 | 0.020 |
 Female | 359 (72.8) | 249 (69.4) | 110 (30.6) |  |  |
 Male | 134 (27.2) | 78 (58.2) | 56 (41.8) |  |  |
Age, mean ± SD (years) | 41.71 ± 11.21 |  |  | 2.570 | 0.109 |
 <55 | 422 (85.6) | 274 (64.9) | 148 (35.1) |  |  |
 ≥55 | 71 (14.4) | 53 (74.6) | 18 (25.4) |  |  |
Maximum tumor size (cm) | Â | Â | Â | 2.022 | 0.155 |
 ≤0.5 | 230 (46.7) | 160 (69.6) | 70 (30.4) |  |  |
 >0.5, ≤1.0 | 263 (53.3) | 167 (63.5) | 96 (36.5) |  |  |
Tumor ___location | Â | Â | Â | 1.481 | 0.477 |
 Left lobe | 211 (42.8) | 146 (69.2) | 65 (30.80) |  |  |
 Right lobe | 267 (54.2) | 172 (64.4) | 95 (35.6) |  |  |
 Isthmus | 15 (3.0) | 9 (60.0) | 6 (40.0) |  |  |
Number of lymph node dissection | Â | Â | Â | 15.415 | <0.001 |
 <6 | 317 (64.3) | 230 (72.6) | 87 (27.4) |  |  |
 ≥6 | 176 (35.7) | 97 (55.1) | 79 (44.9) |  |  |
BRAFV600E mutation | Â | Â | Â | 0.368 | 0.544 |
 Negative | 44 (8.9) | 31 (70.5) | 13 (29.5) |  |  |
 Positive | 449 (91.1) | 296 (65.9) | 153 (34.1) |  |  |
HT | Â | Â | Â | 1.721 | 0.190 |
 Non-concomitant | 419 (85.0) | 273 (65.2) | 146 (34.8) |  |  |
 Concomitant | 74 (15.0) | 54 (73.0) | 20 (27.0) |  |  |
